Literature DB >> 24792643

All bacillus Calmette-Guérin (BCG) strains are equal, but some BCG strains are more equal than others.

Aidan P Noon1, Girish S Kulkarni2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24792643     DOI： 10.1016/j.eururo.2014.04.008

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  3 in total

1.  Are there differences among bacillus Calmette-Guérin (BCG) strains regarding their clinical efficacy in the treatment of non-muscleinvasive bladder cancer? The jury is still out but the answer is likely no.

Authors:  Guan Hee Tan; Cynthia Kuk; Alexandre R Zlotta
Journal:  Can Urol Assoc J       Date:  2019-07-23       Impact factor: 1.862

Review 2.  Intravesical immunotherapy in nonmuscle invasive bladder cancer.

Authors:  Jan-Friedrich Jokisch; Alexander Karl; Christian Stief
Journal:  Indian J Urol       Date:  2015 Oct-Dec

3.  Intravesical High Dose BCG Tokyo and Low Dose BCG Tokyo with GMCSF+IFN α Induce Systemic Immunity in a Murine Orthotopic Bladder Cancer Model.

Authors:  Sin Mun Tham; Juwita N Rahmat; Edmund Chiong; Qinghui Wu; Kesavan Esuvaranathan; Ratha Mahendran
Journal:  Biomedicines       Date:  2021-11-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.